Excited to announce that I will be defending my dissertation with the work from @RafatLab and @JulieRhoadesLab! If you are interested in attending, please let me know!
Komen grantee @BalkoLab presents his work on understanding and improving #breastcancer response to immunotherapy @ #AACR24. To learn more, check out the MBC Impact Series where he discussed his work: https://t.co/GrDksXqNu6
So proud of this outstanding scientist and person @BCT255 defending her thesis today. A @SusanGKomen ASPIRE scholar, @CD_AACR@jitcancer published author and all around superstar. Can't wait to see what the future holds!! @VUMCResearch @VUBasicSciences
I'm defending next week on March 21st at 11:30 am central time.
Stop by to hear about the secrets of CFTR revealed..
DM me for a zoom link
@Plate_Lab and @MeilerLab
We had a very productive 9th Annual Early-Career Hill Day. Our 20 AACR Associate Members are wrapping up their meetings, but you can still take action in support of early-career scientists by visiting
https://t.co/nPx0zHyeBw. #AACRontheHill#FundNIH
Today is the AACR Early-Career National Day of Action, and we're calling on early-career scientists, trainees, students, and all who support them to contact members of Congress and ask them to prioritize @NIH funding. Take action: https://t.co/Lo1wR2a4fu #AACRontheHill#FundNIH
Save the date for Vanderbilt Cancer Biology Graduate Program @melissa_m_wolf's (@KimrynRathmell & @JeffRathmell labs) dissertation defense! “VHL Deficiency and the Tumor Microenvironment in Renal Cell Carcinoma”
Friday, March 1st
3:30 PM
PRB 898J
Join us in two weeks as Emily Hawes (@EmilyMHawes), a graduate student in the lab of Richard O'Brien, presents her dissertation work on the "Regulation of Glucose-6-Phosphatase Catalytic Subunit 2 (G6PC2) Expression and Activity!"
A recent paper from the @balkolab, led by Jamaal James and @bct255, indicates that EZH2 inhibition leads to enhanced MHC-II expression potentially through the improvement of chromatin accessibility at CIITA, the master regulator of MHC-II.
https://t.co/9eoYAdrPgL